Thyrocare Technologies
Thyrocare Technologies Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Thyrocare Technologies
Start SIPThyrocare Technologies Investment Rating
-
Master Rating:
-
Thyrocare Technologies has an operating revenue of Rs. 521.35 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 39% is great, ROE of 33% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 40 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 117 | 125 | 119 | 123 |
| Operating Expenses Qtr Cr | 91 | 96 | 85 | 87 |
| Operating Profit Qtr Cr | 26 | 30 | 34 | 37 |
| Depreciation Qtr Cr | 9 | 8 | 8 | 9 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 5 | 8 | 6 | 9 |
| Net Profit Qtr Cr | 13 | 14 | 20 | 20 |
Thyrocare Technologies Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 448.69
- 50 Day
- 484.3
- 100 Day
- 532.95
- 200 Day
- 609.55
- 20 Day
- 451.67
- 50 Day
- 482.09
- 100 Day
- 550.27
- 200 Day
- 599.71
Thyrocare Technologies Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 429.04 |
| Second Resistance | 436.82 |
| Third Resistance | 443.64 |
| RSI | 31.14 |
| MFI | 22.85 |
| MACD Single Line | -14.94 |
| MACD | -16.37 |
| Support | |
|---|---|
| First Resistance | 414.44 |
| Second Resistance | 407.62 |
| Third Resistance | 399.84 |
Thyrocare Technologies Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 100,185 | 6,704,380 | 66.92 |
| Week | 142,344 | 5,614,038 | 39.44 |
| 1 Month | 79,350 | 3,702,466 | 46.66 |
| 6 Month | 152,010 | 3,924,904 | 25.82 |
Thyrocare Technologies Result Highlights
Thyrocare Technologies Synopsis
NSE-Medical-Services
Thyrocare Tech. is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 561.53 Cr. and Equity Capital is Rs. 52.90 Cr. for the Year ended 31/03/2022. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.| Market Cap | 2,275 |
| Sales | 485 |
| Shares in Float | 1.53 |
| No of funds | 76 |
| Yield | 3.49 |
| Book Value | 4.37 |
| U/D Vol ratio | 0.4 |
| LTDebt / Equity | |
| Alpha | -0.21 |
| Beta | 0.39 |
Thyrocare Technologies
| Owner Name | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|
| Promoters | 71.14% | 71.14% | 71.18% |
| Mutual Funds | 7.3% | 6.81% | 4.72% |
| Insurance Companies | 1.08% | 1.85% | 1.96% |
| Foreign Portfolio Investors | 10.13% | 10.42% | 12.82% |
| Financial Institutions/ Banks | |||
| Individual Investors | 8.07% | 7.28% | 6.72% |
| Others | 2.28% | 2.5% | 2.6% |
Thyrocare Technologies Management
| Name | Designation |
|---|---|
| Mr. Rahul Guha | Managing Director & CEO |
| Mr. Dharmil Sheth | Non Executive Director |
| Mr. Hardik Dedhia | Non Executive Director |
| Mr. Dhaval Shah | Non Executive Director |
| Mr. Gopalkrishna Shivram Hegde | Independent Director |
| Mr. Vishwas Kulkarni | Independent Director |
| Dr. Neetin S Desai | Independent Director |
| Dr. Indumati Gopinathan | Independent Director |
Thyrocare Technologies Forecast
Price Estimates
Thyrocare Technologies FAQs
What is Share Price of Thyrocare Technologies ?
Thyrocare Technologies share price is ₹429 As on 01 April, 2023 | 16:33
What is the Market Cap of Thyrocare Technologies ?
The Market Cap of Thyrocare Technologies is ₹2275.2 Cr As on 01 April, 2023 | 16:33
What is the P/E ratio of Thyrocare Technologies ?
The P/E ratio of Thyrocare Technologies is 31.1 As on 01 April, 2023 | 16:33
What is the PB ratio of Thyrocare Technologies ?
The PB ratio of Thyrocare Technologies is 4.3 As on 01 April, 2023 | 16:33